Xiaohan Zhai
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacological Effects of Natural Compounds
Papers in
-
- Genomics, phytochemicals, and oxidative stress 5
- Mitochondrial Function and Pathology 3
-
- Sirtuins and Resveratrol in Medicine 6
- Co-authors
- Jihong Yao (9 shared papers)Xiaofeng Tian (8 shared papers)Yan Hu (7 shared papers)Musen Lin (6 shared papers)Deshi Dong (14 shared papers)Dongyan Gao (4 shared papers)Linlin Lv (7 shared papers)Xufeng Tao (8 shared papers)
- Journals
- Molecules (3 papers)Frontiers in Pharmacology (3 papers)Environmental Toxicology (2 papers)Biomedicine & Pharmacotherapy (2 papers)Scientific Reports (1 paper)
- Partner nations
- China
In The Last Decade
Xiaohan Zhai
29 papers receiving 736 citations
Peers
Comparison fields: 5 of 91
- Geriatrics and Gerontology 64
- Pharmacology 101
- Biochemistry 46
- Hepatology 61
- Complementary and alternative medicine 57
Countries citing papers authored by Xiaohan Zhai
This map shows the geographic impact of Xiaohan Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohan Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohan Zhai more than expected).
Fields of papers citing papers by Xiaohan Zhai
This network shows the impact of papers produced by Xiaohan Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohan Zhai. The network helps show where Xiaohan Zhai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaohan Zhai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 113 | |
| 2 | 2019 | 84 | |
| 3 | 2014 | 75 | |
| 4 | 2014 | 62 | |
| 5 | 2014 | 50 | |
| 6 | 2013 | 49 | |
| 7 | 2022 | 42 | |
| 8 | 2023 | 42 | |
| 9 | 2014 | 29 | |
| 10 | 2014 | 27 | |
| 11 | 2022 | 25 | |
| 12 | 2023 | 22 | |
| 13 | 2022 | 22 | |
| 14 | 2015 | 18 | |
| 15 | 2015 | 18 | |
| 16 | 2022 | 16 | |
| 17 | 2023 | 14 | |
| 18 | 2023 | 10 | |
| 19 | 2023 | 7 | |
| 20 | 2023 | 6 |
About Xiaohan Zhai
Xiaohan Zhai is a scholar working on Molecular Biology, Geriatrics and Gerontology, Oncology, Epidemiology and Pharmacology, having authored 31 papers that have together received 745 indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Mitochondrial Function and Pathology (3 papers), Computational Drug Discovery Methods (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver Disease and Transplantation (3 papers). The work is most often cited by research in Geriatrics and Gerontology (64 citations), Pharmacology (101 citations), Biochemistry (46 citations), Hepatology (61 citations) and Complementary and alternative medicine (57 citations). Xiaohan Zhai has collaborated with scholars based in China. Frequent co-authors include Jihong Yao, Xiaofeng Tian, Yan Hu, Musen Lin, Deshi Dong, Dongyan Gao, Linlin Lv, Xufeng Tao, Shilei Yang and Xiaochi Ma. Their work appears in journals such as Molecules, Frontiers in Pharmacology, Environmental Toxicology, Biomedicine & Pharmacotherapy and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.